An observational study in Nurse-Patient Relations, sponsored by Nantes University Hospital. Completed at 5 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.
Sponsored by Nantes University Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Pain by Nantes University Hospital — none open to participants now, none under way, none of them phase 3. Pain · Nantes University Hospital.
Among the 12 studies in Pain by Nantes University Hospital, this one is the only one that started in 2024, is one of 5 observational ones, and was the 12th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →None of the 12 studies in Pain by Nantes University Hospital is open now. The open studies under Pain, anywhere →
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 77 is below the median of 100 across 1,253 observational studies indexed under Pain.
Median enrollment 49 across the 7 interventional studies, 78 across the 5 observational. Of the 12 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Nantes University Hospital is the lead sponsor of 839 studies on the registry; 189 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 12 studies in Pain by Nantes University Hospital, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The hypothesis is that the current bedpan is not adapted to the diversity of patients encountered. It is necessary to collect the opinions of patients themselves on the current pool in different departments in order to validate our hypothesis.
The objective is to evaluate pain in patients with reduced or very reduced mobility caused by the bedpan currently used in current practice through an observational study.
Patients with reduced or severely reduced mobility, over 18 years of age, bedridden and requiring the use of a bedpan, estimated hospitalization equal to or greater than 2 days on the ward.
Patients with reduced or severely reduced mobility, over 18 years of age, bedridden and requiring the use of a bedpan, estimated hospitalization equal to or greater than 2 days.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
48-hour follow-up of patients included in the study, with data collected on two pelvis fittings per 24 hours of follow-up (one fitting = one installation and one removal).
Other: Questioning the patient during hygiene care
The study examines how patients and caregivers feel when using the bedpan. Over the course of a day, collecting all this information would take just under 7 minutes. Over the duration of patient participation (2 days), we estimate that it would take a total of 15 minutes per patient to collect this information. The objectives are focused on pain and discomfort, and on the alteration of the (patient's) skin condition through objective observation of redness or stage I pressure sores by the caregiver.
Assessment of pain in a patient with reduced or very reduced mobility when using a bedpan.
Pain will be assessed using a numerical pain scale (EN). The caregiver will ask the patient to rate his or her pain between 0 (no pain) and 10 (the most intense pain imaginable).
Time frame: Four assessments in 48 hours
Assess the proportion of patients with a MCID of the pain felt by the patient in pre-installation > 1.3
Time frame: 48 hours
Assess the maximum pain felt by the patient pre/post and per/post use of the bedpan.
Pain will be assessed using a numerical pain scale (EN). The caregiver will ask the patient to rate his or her pain between 0 (no pain) and 10 (the most intense pain imaginable).
Time frame: 48 hours
Assess patient discomfort on the bedpan
discomfort will be defined by the addition of a cushion, rolled towel, treatment oil or the need for the bedpan to be repositioned
Time frame: 48 hours
Assess alteration of skin condition at the seat of the patient using the bedpan
Appearance of stage I redness or pressure sores (redness that does not disappear) on the patient's seat, after using the bedpan
Time frame: 48 hours
Assess the caregiver's pain when handling the bedpan, placing the bedpan in position and removing the bedpan.
Pain will be assessed using a numerical pain scale (EN). The caregiver will rate his or her pain between 0 (no pain) and 10 (the most intense pain imaginable).
Time frame: 48 hours
Assess the risk factors associated with the onset of pain when placing a bedpan.
Time frame: 48 hours
Assess the difficulty of positioning and removing the bedpan.
Painfulness of placing and removing the bedpan, assessed by the caregiver using a Likert scale between 1 (easy) and 5 (impossible alone)
Time frame: 48 hours
Assess bedpan stability during use
Stability will be evaluated by the tilting, or not, of the bedpan during use by the patient.
Time frame: 48 hours
Evaluate the effect of time spent on the bedpan on: pain, skin alteration and discomfort
Time frame: 48 hours
Plan to share: No
No publications or documents are linked to this record.
Ran from Aug 2024 to primary completion in Jul 2026, 23 months.
Of 505 non-industry observational studies under Pain, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 42. This study's 23 months is above that.
Counting every sponsor, half of 520 studies reached it within 18 months; a quarter within 8 and three quarters within 41.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 9, 2026: primary completion Aug 2026 → Jul 2026 and completion Aug 2026 → Jul 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.